Visfatin has an enzymatic activity that is involved in the transformation of Nicotinamide (NAM) into Nicotinamide Mononucleotide (NMN) [56]; its plasma levels correlate positively with obesity [8] and specifically with the visceral adipose tissue [57]. Here, NAMPT is linked to obesity disorder.